Insider Transactions in Q3 2024 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.05%
|
$250,000
$25.47 P/Share
|
|
Sep 19
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.96%
|
$20,000
$2.06 P/Share
|
|
Sep 18
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.05%
|
$230,000
$23.9 P/Share
|
|
Sep 18
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.96%
|
$20,000
$2.06 P/Share
|
|
Sep 16
2024
|
Garrie Richardson Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
3,070
-2.61%
|
$76,750
$25.12 P/Share
|
|
Sep 16
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
611
-0.49%
|
$15,275
$25.12 P/Share
|
|
Sep 16
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
229
-0.37%
|
$5,725
$25.12 P/Share
|
|
Sep 16
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
343
-0.11%
|
$8,575
$25.12 P/Share
|
|
Sep 16
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
367
-0.34%
|
$9,175
$25.12 P/Share
|
|
Sep 16
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
267
-0.17%
|
$6,675
$25.12 P/Share
|
|
Aug 21
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
142
-0.11%
|
$3,550
$25.61 P/Share
|
|
Aug 21
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
64
-0.1%
|
$1,600
$25.61 P/Share
|
|
Aug 21
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
111
-0.03%
|
$2,775
$25.61 P/Share
|
|
Aug 21
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
82
-0.08%
|
$2,050
$25.61 P/Share
|
|
Aug 21
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
96
-0.06%
|
$2,400
$25.61 P/Share
|
|
Jul 19
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
300
-0.49%
|
$6,300
$21.01 P/Share
|
|
Jul 18
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
240
-0.15%
|
$5,280
$22.5 P/Share
|
|
Jul 11
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
828
-0.66%
|
$16,560
$20.54 P/Share
|
|
Jul 11
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
187
-0.3%
|
$3,740
$20.54 P/Share
|
|
Jul 11
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
313
-0.1%
|
$6,260
$20.54 P/Share
|
|
Jul 11
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
287
-0.26%
|
$5,740
$20.54 P/Share
|
|
Jul 01
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
3,000
-4.64%
|
$63,000
$21.03 P/Share
|